Advertisement
Canada markets open in 6 hours 55 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7297
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    83.02
    +0.17 (+0.21%)
     

  • Bitcoin CAD

    91,162.30
    +247.40 (+0.27%)
     

  • CMC Crypto 200

    1,402.20
    -12.56 (-0.89%)
     

  • GOLD FUTURES

    2,316.00
    -30.40 (-1.30%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,326.25
    -23.75 (-0.14%)
     

  • VOLATILITY

    16.94
    -1.77 (-9.46%)
     

  • FTSE

    8,023.87
    +128.02 (+1.62%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6854
    +0.0004 (+0.06%)
     

READ NOW: Monteverde & Associates PC Investigates the Merger

ACCESSWIRE
·3 min read

NEW YORK, NY / ACCESSWIRE / September 19, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • Maxim Integrated Products, Inc. (NASDAQ:MXIM) relating to its sale to Analog Devices, Inc. Under the terms of the agreement, Maxim shareholders will receive .630 shares of Analog Devices, Inc. common stock for each share of Maxim common stock owned. Click here for more information: https://www.monteverdelaw.com/case/maxim-integrated-products-inc. It is free and there is no cost or obligation to you.

  • Principia Biopharma Inc. (NASDAQ:PRNB) relating to its sale to Sanofi. Under the terms of the agreement, PRNB shareholders will receive $100.00 in cash for each share of PRNB stock they own. Click here for more information: https://www.monteverdelaw.com/case/principia-biopharma-inc. It is free and there is no cost or obligation to you.

  • Varian Medical Systems, Inc. (NYSE:VAR) relating to its sale to Siemens Healthineers AG. Under the terms of the agreement, VAR shareholders will receive $177.50 in cash for each share of VAR common stock owned. Click here for more information: https://www.monteverdelaw.com/case/varian-medical-systems-inc. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

ADVERTISEMENT

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/606867/READ-NOW-Monteverde-Associates-PC-Investigates-the-Merger